These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9352385)

  • 1. Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine.
    Honorati MC; Borzì RM; Dolzani P; Toneguzzi S; Facchini A
    Int J Clin Lab Res; 1997; 27(3):202-6. PubMed ID: 9352385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection.
    Gregorek H; Madaliński K; Woynarowski M; Mikołajewicz J; Syczewska M; Socha J
    Vaccine; 2000 Jan; 18(13):1210-7. PubMed ID: 10649622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic and epidemiologic characterization of non-responders/low-responders to hepatitis B vaccine].
    Ramos I; Oliveira J; Alves V; Côrte-Real R; Santos-Rosa M; Silvestre AM
    Acta Med Port; 2000; 13(4):159-65. PubMed ID: 11155482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of serum IgG subclass distributions and anti-HBs response in healthy adults after hepatitis B vaccination].
    Dinç But A; Ersoy Y; Ozerol IH; Firat M
    Mikrobiyol Bul; 2005 Oct; 39(4):483-90. PubMed ID: 16544550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status.
    Tsai TH; Huang CF; Wei JC; Ho MS; Wang L; Tsai WY; Lin CC; Xu FL; Yang CC
    Viral Immunol; 2006; 19(2):277-84. PubMed ID: 16817770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
    Das K; Gupta RK; Kumar V; Kar P
    World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.
    Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W
    Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
    Doedée AM; Kannegieter N; Öztürk K; van Loveren H; Janssen R; Buisman AM
    Vaccine; 2016 Apr; 34(19):2281-9. PubMed ID: 26721327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
    Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A
    Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy.
    Bagheri-Jamebozorgi M; Keshavarz J; Nemati M; Mohammadi-Hossainabad S; Rezayati MT; Nejad-Ghaderi M; Jamalizadeh A; Shokri F; Jafarzadeh A
    Hum Vaccin Immunother; 2014; 10(12):3731-6. PubMed ID: 25483689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-alpha therapy.
    Gregorek H; Madaliński K; Woynarowski M; Mikolajewicz J; Syczewska M; Socha J
    J Infect Dis; 2000 Jun; 181(6):2059-62. PubMed ID: 10837193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
    Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proportions of IgG subclasses in antibodies formed during vaccination with hepatitis B surface antigen.
    Mattila PS; Pelkonen J; Mäkelä O
    Scand J Immunol; 1986 Dec; 24(6):699-704. PubMed ID: 2948273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
    Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India.
    Hussain Z; Ali SS; Husain SA; Raish M; Sharma DR; Kar P
    World J Gastroenterol; 2005 Dec; 11(45):7165-8. PubMed ID: 16437665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients.
    Almroth G; Uhlin F; Ekermo B; Isaksson B; Kaijser B; Andersson B; Hahn-Zoric M; Sällberg M
    Ups J Med Sci; 2003; 108(1):61-74. PubMed ID: 12903838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.